Thermogenesis announces roll out of readystart cgmp suites for early-stage cell and gene therapy companies

Rancho cordova, calif. , march 15, 2023 /prnewswire/ -- thermogenesis holdings, inc. (nasdaq: thmo), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the company is rolling out a new facility in the sacramento metro area, containing a total of 12, class-7, readystart cgmp suites available for lease by early-stage life science and cell gene therapy ("cgt") companies.
THMO Ratings Summary
THMO Quant Ranking